| ADNP | Genetic | Pharmaceutical | NAP | Mus musculus | 3 |
| ADNP | Genetic | Pharmaceutical | SKIP | Mus musculus | 2 |
| ADNP | Genetic | Pharmaceutical | NAP | Mus musculus | 2 |
| ALDH5A1 | Genetic | Pharmaceutical | CGP 35348 | Mus musculus | 1 |
| ALDH5A1 | Genetic | Pharmaceutical | Vigabatrin | Mus musculus | 1 |
| ARHGAP33 | Genetic | Genetic | Rho deleted Noma-gap protein | Mus musculus | 1 |
| ARHGAP33 | Genetic | Genetic | Wild type Noma-gap protein | Mus musculus | 1 |
| ARID1B | Genetic | Pharmaceutical | recombinant human insulin like growth factor 1 | Mus musculus | 1 |
| ARID1B | Genetic | Pharmaceutical | recombinant mouse growth hormone | Mus musculus | 1 |
| BAIAP2 | Genetic | Pharmaceutical | Memantine | Mus musculus | 1 |
| BAIAP2 | Genetic | Pharmaceutical | MPEP | Mus musculus | 1 |
| BCKDK | Genetic | Dietary | Branched-chain amino acid diet | Mus musculus | 1 |
| ARHGAP32 | Genetic | Pharmaceutical | Clonazepam | Mus Musculus | 1 |
| ARHGAP33 | Genetic | Genetic | One Cdc42 copy knocked out | Mus musculus | 2 |
| ASH1L | Genetic | Genetic | Il-6 knockout | Mus musculus | 1 |
| ATP1A3 | Genetic | Pharmaceutical | Lithium | Mus musculus | 1 |
| BCKDK | Genetic | Dietary | High protein diet | Mus musculus | 1 |
| CHD8 | Genetic | Genetic | human CHD8 | Mus musculus | 1 |
| CHD8 | Genetic | Genetic | stablized Ctnnb1(S37A) | Mus musculus | 1 |
| CNTNAP2 | Genetic | Pharmaceutical | Arginine vasopressin | Mus musculus | 3 |
| BRINP1 | Genetic | Pharmaceutical | Methylphenidate | Mus musculus | 1 |
| CHD2 | Genetic | Transplantation | MGE progenitor cells | Mus musculus | 1 |
| CHD7 | Genetic | Genetic | Reelin gene expression | Mus musculus | 1 |
| CHD8 | Genetic | Pharmaceutical | CPI-455 | Mus musculus | 1 |
| CHD8 | Genetic | Genetic | stablized Ctnnb1(S37A) | Mus musculus | 1 |
| CNTNAP2 | Genetic | Genetic | Human CNTNAP2 | Mus musculus | 1 |
| CNTNAP2 | Genetic | Pharmaceutical | Arginine vasopressin;L371,257 | Mus musculus | 1 |
| CNTNAP2 | Genetic | Pharmaceutical | Arginine vasopressin;Relcovaptan | Mus musculus | 1 |
| CNTNAP2 | Genetic | Genetic | DREADD-Oxytocin neurons | Mus musculus | 1 |
| CNTNAP2 | Genetic | Pharmaceutical | Fenobam | Mus musculus | 1 |
| CNTNAP2 | Genetic | Pharmaceutical | Flumazenil | Mus musculus | 1 |
| CNTNAP2 | Genetic | Pharmaceutical | Fluoxetine | Mus musculus | 1 |
| CNTNAP2 | Genetic | Pharmaceutical | Oxytocin | Mus musculus | 4 |
| CNTNAP2 | Genetic | Pharmaceutical | Oxytocin;L371,257 | Mus musculus | 1 |
| CNTNAP2 | Genetic | Pharmaceutical | Risperidone | Mus musculus | 1 |
| CNTNAP2 | Genetic | Pharmaceutical | Ro27-3225 | Mus musculus | 2 |
| CNTNAP2 | Genetic | Pharmaceutical | Ro27-3225;L371,257 | Mus musculus | 1 |
| FMR1 | Genetic | Pharmaceutical | Minocycline | Drosophila melanogaster | 4 |
| DEAF1 | Genetic | Genetic | paternal DEAF1 | Drosophila melanogaster | 1 |
| DEAF1 | Genetic | Genetic | paternal DEAF1 | Drosophila melanogaster | 1 |
| CNTNAP2 | Genetic | Procedural | Parvalbumin neuron activation | Mus musculus | 1 |
| CNTNAP2 | Genetic | Procedural | Pyramidal neuron activation | Mus musculus | 1 |
| CNTNAP4 | Genetic | Pharmaceutical | Haloperidol | Mus musculus | 1 |
| CNTNAP4 | Genetic | Pharmaceutical | Indipnol | Mus musculus | 1 |
| CNTNAP4 | Genetic | Pharmaceutical | Indipnol | Mus musculus | 1 |
| EIF4EBP2 | Genetic | Pharmaceutical | 4EGI-1 | Mus musculus | 1 |
| EIF4EBP2 | Genetic | Genetic | shRNAs against Nlgn1 | Mus musculus | 1 |
| EIF4EBP2 | Genetic | Genetic | shRNAs against Nlgn2 | Mus musculus | 1 |
| CYFIP1 | Genetic | Procedural | Motor training | Mus musculus | 1 |
| DISC1 | Genetic | Genetic | Clozapine | Mus musculus | 1 |
| DVL1 | Genetic | Pharmaceutical | CHIR99021 | Mus musculus | 1 |
| DVL1 | Genetic | Pharmaceutical | CHIR99021 | Mus musculus | 1 |
| DVL3 | Genetic | Pharmaceutical | CHIR99021 | Mus musculus | 1 |
| EIF4E | Genetic | Pharmaceutical | 4EGI-1 | Mus musculus | 1 |
| FGFR2 | Genetic | Genetic | Reinstatement of Fgfr2 | Mus musculus | 1 |
| FMR1 | Genetic | Pharmaceutical | Acamprosate | Drosophila melanogaster | 2 |
| FMR1 | Genetic | Genetic | dfmr1 | Drosophila melanogaster | 1 |
| FMR1 | Genetic | Genetic | mmp1^Q112 | Drosophila melanogaster | 1 |
| FMR1 | Genetic | Genetic | Timp | Drosophila melanogaster | 1 |
| FMR1 | Genetic | Genetic | Drac1(N17) | Drosophila melanogaster | 1 |
| FMR1 | Genetic | Genetic | Drac1(V12) | Drosophila melanogaster | 1 |
| FMR1 | Genetic | Pharmaceutical | LIM domain kinase 1 | Drosophila melanogaster | 1 |
| FMR1 | Genetic | Pharmaceutical | LIM domain kinase 1 | Drosophila melanogaster | 1 |
| FMR1 | Genetic | Pharmaceutical | Puromycin | Drosophila melanogaster | 1 |
| FMR1 | Genetic | Pharmaceutical | TH251 | Drosophila melanogaster | 1 |
| FMR1 | Genetic | Pharmaceutical | TH255 | Drosophila melanogaster | 1 |
| FMR1 | Genetic | Pharmaceutical | TH263 | Drosophila melanogaster | 1 |
| FMR1 | Genetic | Genetic | wit mutation | Drosophila melanogaster | 1 |
| FMR1 | Genetic | Pharmaceutical | Lithium | Drosophila melanogaster | 2 |
| FMR1 | Genetic | Pharmaceutical | MPEP | Drosophila melanogaster | 5 |
| FMR1 | Genetic | Pharmaceutical | LIM domain kinase 1 | Drosophila melanogaster | 1 |
| FMR1 | Genetic | Genetic | futsch mutation | Drosophila melanogaster | 1 |
| FMR1 | Genetic | Pharmaceutical | LY-341,495 | Drosophila melanogaster | 2 |
| FMR1 | Genetic | Genetic | dunce mutation | Drosophila melanogaster | 1 |
| FMR1 | Genetic | Pharmaceutical | MPPG | Drosophila melanogaster | 1 |
| FMR1 | Genetic | Pharmaceutical | MTPG | Drosophila melanogaster | 2 |
| FMR1 | Genetic | Pharmaceutical | Ro-20-1724 | Drosophila melanogaster | 1 |
| FMR1 | Genetic | Pharmaceutical | Rolipram | Drosophila melanogaster | 2 |
| FMR1 | Genetic | Pharmaceutical | BW-723C86;MDL-11,939 | Mus musculus | 2 |
| FMR1 | Genetic | Genetic | dfmr1^wt transgene | Drosophila melanogaster | 1 |
| FMR1 | Genetic | Genetic | dfmr1^wt transgene | Drosophila melanogaster | 1 |
| FMR1 | Genetic | Genetic | inactivation of one allele of App gene | Mus musculus | 1 |
| FMR1 | Genetic | Pharmaceutical | CTEP | Mus musculus | 2 |
| FMR1 | Genetic | Pharmaceutical | BW-723C86;MDL-11,939;SKF-81,297;Sulpiride | Mus musculus | 1 |
| FMR1 | Genetic | Pharmaceutical | SKF-81,297;Sulpiride | Mus musculus | 2 |
| FMR1 | Genetic | Pharmaceutical | CX-4945 | Mus musculus | 1 |
| FMR1 | Genetic | Pharmaceutical | Lithium | Mus musculus | 2 |
| FMR1 | Genetic | Pharmaceutical | MPEP | Mus musculus | 1 |
| FMR1 | Genetic | Pharmaceutical | Minocycline | Mus musculus | 3 |
| FMR1 | Genetic | Pharmaceutical | JQ1 | Mus musculus | 3 |
| FMR1 | Genetic | Pharmaceutical | CX-4945;JQ1 | Mus musculus | 1 |
| FMR1 | Genetic | Pharmaceutical | CTEP | Mus musculus | 2 |
| FMR1 | Genetic | Pharmaceutical | Bumetanide | Mus musculus | 2 |
| FMR1 | Genetic | Pharmaceutical | FRAX486 | Mus musculus | 12 |
| FMR1 | Genetic | Pharmaceutical | Minocycline | Mus musculus | 1 |
| FMR1 | Genetic | Genetic | inactivation of one copy of S6K1 | Mus musculus | 1 |
| FMR1 | Genetic | Genetic | inactivation of S6K1 gene | Mus musculus | 1 |
| GABRB3 | Genetic | Pharmaceutical | Baclofen | Mus musculus | 1 |
| GABRB3 | Genetic | Pharmaceutical | Carbamazepine | Mus musculus | 1 |
| FOLH1 | Genetic | Dietary | Low folate diet | Mus musculus | 2 |
| GABRB3 | Genetic | Pharmaceutical | CGP 35348 | Mus musculus | 1 |
| GABRB3 | Genetic | Pharmaceutical | Clonazepam | Mus musculus | 1 |
| GABRB3 | Genetic | Pharmaceutical | Ethosuximide | Mus musculus | 1 |
| GABRB3 | Genetic | Pharmaceutical | THIP | Mus musculus | 1 |
| GABRB3 | Genetic | Pharmaceutical | Valproic acid | Mus musculus | 1 |
| GRIK2 | Genetic | Pharmaceutical | Fluoxetine | Mus musculus | 1 |
| GRIK4 | Genetic | Pharmaceutical | Fluoxetine | Mus musculus | 1 |
| GRIK4 | Genetic | Genetic | Grik-null | Mus musculus | 1 |
| GRIK4 | Genetic | Pharmaceutical | IEM1460 | Mus musculus | 1 |
| GRIK4 | Genetic | Pharmaceutical | Tianeptine | Mus musculus | 1 |
| GRIK4 | Genetic | Pharmaceutical | UBP310 | Mus musculus | 1 |
| GRIN1 | Genetic | Pharmaceutical | Baclofen | Mus musculus | 1 |
| GRIN1 | Genetic | Pharmaceutical | L-838,417 | Mus musculus | 1 |
| GRIN1 | Genetic | Pharmaceutical | Risperidone | Mus musculus | 1 |
| IFNG | Genetic | Pharmaceutical | Diazepam | Mus musculus | 1 |
| IFNG | Genetic | Pharmaceutical | Interferon gamma | Mus musculus | 1 |
| MECP2 | Genetic | Pharmaceutical | 7,8-Dihydroxyflavone | Mus musculus | 1 |
| LRRC4 | Genetic | Pharmaceutical | D-Cycloserine | Mus musculus | 3 |
| MECP2 | Genetic | Pharmaceutical | CX-546 | Mus musculus | 1 |
| MECP2 | Genetic | Pharmaceutical | Acetyl-L-carnitine | Mus musculus | 1 |
| MECP2 | Genetic | Pharmaceutical | D-Cycloserine | Mus musculus | 1 |
| MECP2 | Genetic | Pharmaceutical | Antalarmin | Mus musculus | 1 |
| MECP2 | Genetic | Genetic | one copy of Crh knocked out | Mus musculus | 1 |
| MECP2 | Genetic | Genetic | One copy of Crhr1 knocked out | Mus musculus | 1 |
| MECP2 | Genetic | Pharmaceutical | Cysteamine | Mus musculus | 1 |
| MECP2 | Genetic | Pharmaceutical | RU-486 | Mus musculus | 1 |
| MECP2 | Genetic | Pharmaceutical | Acetyl-L-carnitine | Mus musculus | 1 |
| MECP2 | Genetic | Genetic | One copy of Oprm1 knocked out | Mus musculus | 1 |
| MECP2 | Genetic | Genetic | Reducing Mecp2 expression from transgene | Mus musculus | 1 |
| MECP2 | Genetic | Genetic | MECP2-dNIC | Mus musculus | 1 |
| MECP2 | Genetic | Genetic | MECP2-dNIC | Mus musculus | 1 |
| MECP2 | Genetic | Pharmaceutical | RU-486 | Mus musculus | 1 |
| NF1 | Genetic | Genetic | Reinstate Nf1 | Drosophila melanogaster | 1 |
| NF1 | Genetic | Genetic | Reinstate Nf1 in central brain neurons | Drosophila melanogaster | 1 |
| NF1 | Genetic | Genetic | Reinstate Nf1 in central clock neurons | Drosophila melanogaster | 1 |
| MECP2 | Genetic | Pharmaceutical | D-Cycloserine | Mus musculus | 1 |
| MECP2 | Genetic | Pharmaceutical | Fenobam | Mus musculus | 1 |
| MECP2 | Genetic | Pharmaceutical | SCH-23390 | Mus musculus | 1 |
| MECP2 | Genetic | Pharmaceutical | SCH-39166 | Mus musculus | 1 |
| MEF2C | Genetic | Pharmaceutical | Memantine | Mus musculus | 1 |
| MEF2C | Genetic | Pharmaceutical | NitroSynapsin | Mus musculus | 1 |
| MIR137 | Genetic | Genetic | Ablation of Pde10a | Mus musculus | 1 |
| MIR137 | Genetic | Pharmaceutical | Papaverine | Mus musculus | 1 |
| NEGR1 | Genetic | Genetic | Fgfr2 cDNA | Mus musculus | 1 |
| NEGR1 | Genetic | Genetic | Reinstatement of Negr1 | Mus musculus | 1 |
| NF1 | Genetic | Genetic | Reinstate Nf1 in cholinergic neurons | Drosophila melanogaster | 1 |
| NF1 | Genetic | Genetic | Reinstate Nf1 in DH44 producing neurons | Drosophila melanogaster | 1 |
| NF1 | Genetic | Genetic | Reinstate Nf1 in DN1 clock neurons | Drosophila melanogaster | 1 |
| NF1 | Genetic | Genetic | Reinstate Nf1 in DN1 clock neurons and nonclock neurons | Drosophila melanogaster | 1 |
| NF1 | Genetic | Genetic | Reinstate Nf1 in Kenyon cells | Drosophila melanogaster | 2 |
| NF1 | Genetic | Genetic | Reinstate Nf1 in lateral-protocerebrum | Drosophila melanogaster | 1 |
| NF1 | Genetic | Genetic | Reinstate Nf1 in monoaminergic neurons | Drosophila melanogaster | 2 |
| NF1 | Genetic | Genetic | Reinstate Nf1 in mushroom body | Drosophila melanogaster | 2 |
| NF1 | Genetic | Genetic | Reinstate Nf1 in mushroom body-gamma neurons | Drosophila melanogaster | 1 |
| NF1 | Genetic | Genetic | Reinstate Nf1 in neurons | Drosophila melanogaster | 1 |
| NF1 | Genetic | Genetic | Reinstate Nf1 in pars intercerebralis | Drosophila melanogaster | 1 |
| NF1 | Genetic | Genetic | Reinstate Nf1 in peptidergic neurons | Drosophila melanogaster | 1 |
| NF1 | Genetic | Genetic | Reinstate Nf1 in whole brain | Drosophila melanogaster | 1 |
| PTEN | Genetic | Genetic | S6k loss | Drosophila melanogaster | 1 |
| NLGN3 | Genetic | Genetic | DIO-NL3 transgene in nucleus accumbens | Mus musculus | 1 |
| NLGN3 | Genetic | Genetic | Nlgn3 | Mus musculus | 4 |
| NLGN3 | Genetic | Genetic | NLGN3 | Mus musculus | 1 |
| NLGN3 | Genetic | Genetic | Optogenetic activation of Pvalb interneurons | Mus musculus | 1 |
| NLGN3 | Genetic | Pharmaceutical | ACEA | Mus musculus | 1 |
| NLGN3 | Genetic | Pharmaceutical | HU-210 | Mus musculus | 1 |
| NLGN3 | Genetic | Pharmaceutical | Quinpirole | Mus musculus | 1 |
| NLGN3 | Genetic | Pharmaceutical | URB597 | Mus musculus | 1 |
| OPRM1 | Genetic | Behavioral | Double mothering - social enrichment | Mus musculus | 1 |
| OPRM1 | Genetic | Pharmaceutical | Oxytocin | Mus musculus | 1 |
| OXTR | Genetic | Pharmaceutical | Cocaine | Mus musculus | 1 |
| OXTR | Genetic | Dietary | Lactobacillus reuteri | Mus musculus | 1 |
| NLGN3 | Genetic | Genetic | Nlgn3 reexpression | Mus musculus | 1 |
| OXTR | Genetic | Pharmaceutical | Oxytocin | Mus musculus | 1 |
| OXTR | Genetic | Pharmaceutical | Arginine vasopressin | Mus musculus | 1 |
| OXTR | Genetic | Pharmaceutical | Oxytocin | Mus musculus | 1 |
| OXT | Genetic | Pharmaceutical | Arginine vasopressin | Mus musculus | 1 |
| OXT | Genetic | Pharmaceutical | Ota-vasotocin | Mus musculus | 1 |
| OXT | Genetic | Pharmaceutical | Oxytocin | Mus musculus | 1 |
| OXT | Genetic | Genetic; Induced | CB1 receptor antagonist | Mus musculus | 1 |
| OXT | Genetic | Genetic | Pregnancy | Mus musculus | 1 |
| PAK2 | Genetic | Genetic | Phospho-cofilin peptide | Mus musculus | 1 |
| PLPPR4 | Genetic | Genetic | H253K-PLPPR4 | Mus musculus | 1 |
| PLPPR4 | Genetic | Genetic | LPA2R | Mus musculus | 1 |
| PLPPR4 | Genetic | Genetic | PLPPR4 | Mus musculus | 1 |
| PTCHD1 | Genetic | Pharmaceutical | Amphetamine | Mus musculus | 1 |
| PTCHD1 | Genetic | Pharmaceutical | EBIO | Mus musculus | 1 |
| PCDH10 | Genetic | Pharmaceutical | D-Cycloserine | Mus musculus | 1 |
| PRKDC | Genetic | Transplantation | Lymphocytes | Mus musculus | 1 |
| PTEN | Genetic | Pharmaceutical | Rapamycin | Mus musculus | 2 |
| RAI1 | Genetic | Procedural | PFC activation | Mus musculus | 2 |
| RAI1 | Genetic | Genetic | Reinstatement of Rai1 | Mus musculus | 4 |
| PTEN | Genetic | Dietary | Fasting | Mus musculus | 1 |
| RELN | Genetic | Pharmaceutical | Estradiol | Mus musculus | 1 |
| SHANK2 | Genetic | Pharmaceutical | CDPPB | Mus musculus | 2 |
| SCN1A | Genetic | Pharmaceutical | Clonazepam | Mus musculus | 1 |
| SCN2A | Genetic | Biological | Ampalex | Mus musculus | 1 |
| SHANK2 | Genetic | Pharmaceutical | D-Cycloserine | Mus musculus | 1 |
| SHANK2 | Genetic | Pharmaceutical | Clioquinol | Mus musculus | 1 |
| SHANK2 | Genetic | Pharmaceutical | D-Cycloserine | Mus musculus | 1 |
| SHANK2 | Genetic | Pharmaceutical | Memantine | Mus musculus | 4 |
| SHANK3 | Genetic | Pharmaceutical | CDPPB | Mus musculus | 2 |
| SHANK2 | Genetic | Pharmaceutical | L-838,417 | Mus musculus | 1 |
| SHANK2 | Genetic | Pharmaceutical | L-838,417 | Mus musculus | 1 |
| SHANK3 | Genetic | Genetic | Reinstatement of Shank3 | Mus musculus | 1 |
| SHANK3 | Genetic | Pharmaceutical | MPEP | Mus musculus | 1 |
| SHANK3 | Genetic | Pharmaceutical | Insulin-like growth factor 1 | Mus musculus | 2 |
| SHANK3 | Genetic | Pharmaceutical | Insulin-like growth factor 1 peptide derivative | Mus musculus | 1 |
| SHANK3 | Genetic | Pharmaceutical | Cocaine | Mus musculus | 1 |
| SHANK3 | Genetic | Genetic | Reinstatement of Shank3 | Mus musculus | 2 |
| SHANK3 | Genetic | Transplantation | Lactobacillus reuteri | Mus musculus | 2 |
| SHANK3 | Genetic | Dietary | Lactobacillus reuteri | Mus musculus | 2 |
| SHANK3 | Genetic | Dietary | Zinc | Mus musculus | 1 |
| SHANK3 | Genetic | Pharmaceutical | 7,8-Dihydroxyflavone | Mus musculus | 1 |
| SHANK3 | Genetic | Pharmaceutical | CX-546 | Mus musculus | 1 |
| SHANK3 | Genetic | Pharmaceutical | D-Cycloserine | Mus musculus | 2 |
| SHANK3 | Genetic | Pharmaceutical | Oxytocin | Mus musculus | 1 |
| SHANK3 | Genetic | Pharmaceutical | TG003 | Mus musculus | 1 |
| SHANK3 | Genetic | Genetic | constititutively active Rac1 | Mus musculus | 1 |
| SHANK3 | Genetic | Pharmaceutical | Romidepsin | Mus musculus | 4 |
| SHANK3 | Genetic | Pharmaceutical | Aripiprazole | Mus musculus | 1 |
| SHANK3 | Genetic | Genetic | beta-catenin sh RNA | Mus musculus | 1 |
| SHANK3 | Genetic | Pharmaceutical | Clozapine | Mus musculus | 1 |
| SHANK3 | Genetic | Pharmaceutical | Fluoxetine | Mus musculus | 1 |
| SHANK3 | Genetic | Genetic | Hdac2 shRNA | Mus musculus | 2 |
| SHANK3 | Genetic | Pharmaceutical | Phospho-cofilin peptide | Mus musculus | 3 |
| UBE3A | Genetic | Genetic | Expression of drrl | Drosophila melanogaster | 1 |
| UBE3A | Genetic | Genetic | Expression of human Ube3a | Drosophila melanogaster | 1 |
| UBE3A | Genetic | Genetic | Expression of Ube3a-C941A | Drosophila melanogaster | 1 |
| UBE3A | Genetic | Genetic | Reinstate Ube3a | Drosophila melanogaster | 2 |
| UBE3A | Genetic | Genetic | Ube3a^+ | Drosophila melanogaster | 1 |
| UBE3A | Genetic | Genetic | Ube3a^C941A | Drosophila melanogaster | 1 |
| SHANK3 | Genetic | Pharmaceutical | Risperidone | Mus musculus | 1 |
| UBE3A | Genetic | Genetic | Expression of human Ube3a | Drosophila melanogaster | 1 |
| UBE3A | Genetic | Genetic | Expression of human Ube3a | Drosophila melanogaster | 1 |
| SHANK3 | Genetic | Pharmaceutical | TG003 | Mus musculus | 1 |
| SHANK3 | Genetic | Pharmaceutical | Trichostatin A | Mus musculus | 1 |
| SHANK3 | Genetic | Pharmaceutical | Valproic acid | Mus musculus | 1 |
| SLC1A2 | Genetic | Pharmaceutical | Desloratadine | Mus musculus | 1 |
| SLC1A2 | Genetic | Pharmaceutical | Fluoxetine | Mus musculus | 2 |
| SLC1A2 | Genetic | Pharmaceutical | Memantine | Mus musculus | 1 |
| SLC6A3 | Genetic | Pharmaceutical | Clozapine | Mus musculus | 1 |
| SLC6A3 | Genetic | Pharmaceutical | Haloperidol | Mus musculus | 1 |
| SLC6A3 | Genetic | Pharmaceutical | Pregnenolone | Mus musculus | 1 |
| SLC6A4 | Genetic | Genetic | Ablation of Mapk14 | Mus musculus | 1 |
| SLC6A4 | Genetic | Pharmaceutical | MW108 | Mus musculus | 2 |
| SLC6A4 | Genetic | Pharmaceutical | MW150 | Mus musculus | 2 |
| Slc30a3 | Genetic | Pharmaceutical | Minocycline | Mus musculus | 1 |
| SLC33A1 | Genetic | Genetic | Suppression of the human SLC33A1 human transgene | Mus musculus | 1 |
| SLC6A4 | Genetic | Pharmaceutical | Prucalopride | Mus musculus | 1 |
| SLC7A5 | Genetic | Pharmaceutical | Branched-chained amino acids | Mus musculus | 1 |
| ST8SIA2 | Genetic | Pharmaceutical | D-Cycloserine | Mus musculus | 3 |
| STXBP1 | Genetic | Pharmaceutical | Levetiracetam | Mus musculus | 2 |
| TAOK2 | Genetic | Genetic | TAOK2ab-A135P | Mus musculus | 1 |
| TAOK2 | Genetic | Genetic | TAOK2b-P1022 | Mus musculus | 1 |
| TAOK2 | Genetic | Genetic | WT-TAOK2ab | Mus musculus | 1 |
| TBR1 | Genetic | Pharmaceutical | D-Cycloserine | Mus musculus | 2 |
| TBR1 | Genetic | Genetic | in utero electroporation of micro-RNA- Cdh8 and Ntng1 | Mus musculus | 1 |
| TBR1 | Genetic | Genetic | Clioquinone | Mus musculus | 1 |
| SYN2 | Genetic | Pharmaceutical | THIP | Mus musculus | 1 |
| TBR1 | Genetic | Pharmaceutical | D-Cycloserine | Mus musculus | 1 |
| TCF4 | Genetic | Genetic | Hdac2 shRNAs | Mus musculus | 1 |
| TCF4 | Genetic | Pharmaceutical | SAHA | Mus musculus | 1 |
| TSC1 | Genetic | Procedural | Left crus I Purkinje neuron stimulation | Mus musculus | 1 |
| TSC1 | Genetic | Procedural | Right crus I Purkinje neuron stimulation | Mus musculus | 1 |
| AVP | Genetic | Pharmaceutical | Clozapine | Rattus norvegicus | 2 |
| AVP | Genetic | Pharmaceutical | Haloperidol | Rattus norvegicus | 1 |
| AVP | Genetic | Pharmaceutical | PD149163 | Rattus norvegicus | 2 |
| TBR1 | Genetic | Genetic | Reinstatement of Wnt7b | Mus musculus | 2 |
| TERT | Genetic | Pharmaceutical | Memantine | Mus musculus | 1 |
| TRPC6 | Genetic | Genetic | TRPC6-WTR-sh-RNA | Mus musculus | 1 |
| DRD1 | Genetic | Pharmaceutical | Neutrophil inhibitory factor | Rattus norvegicus | 1 |
| DRD1 | Genetic | Pharmaceutical | Neutrophil inhibitory factor | Rattus norvegicus | 1 |
| NRXN1 | Genetic | Procedural | Amygdala activation | Rattus norvegicus | 1 |
| SHANK2 | Genetic | Pharmaceutical | JNJ-16259685 | Rattus norvegicus | 1 |
| SHANK2 | Genetic | Pharmaceutical | SCH-39166 | Rattus norvegicus | 2 |
| SLC6A3 | Genetic | Pharmaceutical | Clonidine | Rattus norvegicus | 1 |
| SLC6A3 | Genetic | Pharmaceutical | Fluoxetine | Rattus norvegicus | 1 |
| SLC6A3 | Genetic | Pharmaceutical | Quinpirole | Rattus norvegicus | 1 |
| TCF4 | Genetic | Pharmaceutical | A803476 | Rattus norvegicus | 1 |
| TCF4 | Genetic | Pharmaceutical | UCL2077 | Rattus norvegicus | 1 |
| KCNJ10 | Genetic | Genetic | R18Q-Kir4.1 | Danio rerio | 1 |
| KCNJ10 | Genetic | Genetic | R271C-Kir4.1 | Danio rerio | 1 |
| KCNJ10 | Genetic | Genetic | R348H-Kir4.1 | Danio rerio | 1 |
| KCNJ10 | Genetic | Genetic | V84M-Kir4.1 | Danio rerio | 1 |
| PAX6 | Genetic | Pharmaceutical | Clozapine | Rattus norvegicus | 1 |
| PCDH19 | Genetic | Genetic | hPCDH19 | Rattus norvegicus | 1 |
| SCN1A | Genetic | Pharmaceutical | Methylphenidate | Rattus norvegicus | 1 |
| SHANK3 | Genetic | Pharmaceutical | Oxytocin | Rattus norvegicus | 1 |
| SHANK3 | Genetic | Pharmaceutical | Oxytocin | Rattus norvegicus | 1 |
| KCNJ10 | Genetic | Genetic | wt-Kir4.1 | Danio rerio | 1 |
| KCTD13 | Genetic | Genetic | BBS7 | Danio rerio | 1 |
| KCTD13 | Genetic | Genetic | cep290 MO | Danio rerio | 1 |
| KCTD13 | Genetic | Genetic | cep290 RNA | Danio rerio | 1 |
| KCTD13 | Genetic | Genetic | BBS7 | Danio rerio | 1 |
| CEP290 | Genetic | Genetic | cep290 MO | Danio rerio | 1 |
| KCTD13 | Genetic | Genetic | CEP290 RNA | Danio rerio | 1 |
| MECP2 | Genetic | Genetic | HuC mecp2 | Danio rerio | 1 |
| MECP2 | Genetic | Genetic | mecp2 mRNA | Danio rerio | 1 |
| MECP2 | Genetic | Genetic | robo mRNA; sema5b mRNA | Danio rerio | 1 |
| MECP2 | Genetic | Genetic | robo2 mRNA | Danio rerio | 1 |
| MECP2 | Genetic | Genetic | sema5b mRNA | Danio rerio | 1 |
| MECP2 | Genetic | Genetic | mecp2 mRNA | Danio rerio | 2 |
| MECP2 | Genetic | Genetic | tnfa mRNA | Danio rerio | 1 |
| KCNJ10 | Genetic | Genetic | wt-Hu-Kir4.1mRNA | Danio rerio | 1 |
| KDM6A | Genetic | Genetic | Reinstatement of kdm6a | Danio rerio | 1 |
| RHEB | Genetic | Pharmaceutical | Rapamycin | Danio rerio | 1 |
| RHEB | Genetic | Pharmaceutical | Rapamycin | Danio rerio | 1 |
| RLIM | Genetic | Genetic | hu-rlim-wt mRNA | Danio rerio | 1 |
| RLIM | Genetic | Genetic | rlim^Arg365Cys | Danio rerio | 1 |
| RLIM | Genetic | Genetic | rlim^Arg387Cys | Danio rerio | 1 |
| RLIM | Genetic | Genetic | rlim^Arg599Cys | Danio rerio | 1 |
| RLIM | Genetic | Genetic | rlim^Arg611Cys | Danio rerio | 1 |
| RLIM | Genetic | Genetic | rlim^Asn178Thr | Danio rerio | 1 |
| RLIM | Genetic | Genetic | rlim^Pro587Arg | Danio rerio | 1 |
| RLIM | Genetic | Genetic | rlim^Pro77Leu | Danio rerio | 1 |
| RLIM | Genetic | Genetic | rlim^Tyr356Cys | Danio rerio | 1 |
| RPL10 | Genetic | Genetic | hRPL10 | Danio rerio | 1 |
| RPL10 | Genetic | Genetic | hRPL10-H213Q | Danio rerio | 1 |
| RPL10 | Genetic | Genetic | hRPL10-K78E | Danio rerio | 1 |
| RPL10 | Genetic | Genetic | hRPL10-L206M | Danio rerio | 1 |
| RPL10 | Genetic | Genetic | hRPL10-S202N | Danio rerio | 1 |
| RHEB | Genetic | Pharmaceutical | Rapamycin | Danio rerio | 1 |
| TSC1 | Genetic | Pharmaceutical | D-Cycloserine | Mus musculus | 1 |
| TSC1 | Genetic | Pharmaceutical | Fenobam | Mus musculus | 1 |
| TSC1 | Genetic | Pharmaceutical | SCH-23390 | Mus musculus | 1 |
| TSC1 | Genetic | Pharmaceutical | SCH-39166 | Mus musculus | 1 |
| TSC1 | Genetic | Pharmaceutical | Rapamycin | Mus musculus | 1 |
| TSC1 | Genetic | Pharmaceutical | Rapamycin | Mus musculus | 1 |
| TSC1 | Genetic | Pharmaceutical | Rapamycin | Mus musculus | 3 |
| TSC1 | Genetic | Pharmaceutical | Rapamycin | Mus musculus | 1 |
| TSC1 | Genetic | Pharmaceutical | Rapamycin | Mus musculus | 6 |
| TSC2 | Genetic | Pharmaceutical | Rapamycin | Mus musculus | 1 |
| TSC2 | Genetic | Pharmaceutical | Rapamycin | Mus musculus | 4 |
| UBE3A | Genetic | Genetic | Reinstatement of Ube3a in GABAergic neurons | Mus musculus | 1 |
| UBE3A | Genetic | Genetic | Reinstatement of Ube3a in glutamatergic neurons | Mus musculus | 1 |
| UBE3A | Multifactorial | Genetic | Cbln1 expression | Mus musculus | 1 |
| UBE3A | Genetic | Pharmaceutical | THIP | Mus musculus | 2 |
| UBE3A | Genetic | Pharmaceutical | Apamin | Mus musculus | 1 |
| UPF3B | Genetic | Pharmaceutical | Haloperidol | Mus musculus | 1 |
| TSC2 | Genetic | Pharmaceutical | Everolimus | Rattus norvegicus | 1 |